vs
Side-by-side financial comparison of Kartoon Studios, Inc. (TOON) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Kartoon Studios, Inc. is the larger business by last-quarter revenue ($9.7M vs $5.5M, roughly 1.8× Taysha Gene Therapies, Inc.). Kartoon Studios, Inc. runs the higher net margin — -54.4% vs -507.8%, a 453.4% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 2.9%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs 26.3%).
Kartoon Studios, Inc. is an entertainment company headed by Andy Heyward. The company was formed in 2010 as Genius Brands International (GBI) from the merger of Genius Brands International and A Squared Entertainment.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
TOON vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.7M | $5.5M |
| Net Profit | $-5.3M | $-27.9M |
| Gross Margin | — | — |
| Operating Margin | -38.4% | -516.0% |
| Net Margin | -54.4% | -507.8% |
| Revenue YoY | 2.9% | 171.3% |
| Net Profit YoY | 8.5% | -48.3% |
| EPS (diluted) | $-0.08 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.7M | $5.5M | ||
| Q3 25 | $9.9M | $0 | ||
| Q2 25 | $10.3M | $2.0M | ||
| Q1 25 | $9.5M | $2.3M | ||
| Q4 24 | $9.4M | $2.0M | ||
| Q3 24 | $8.7M | $1.8M | ||
| Q2 24 | $8.4M | $1.1M | ||
| Q1 24 | $6.1M | $3.4M |
| Q4 25 | $-5.3M | $-27.9M | ||
| Q3 25 | $-6.6M | $-32.7M | ||
| Q2 25 | $-6.2M | $-26.9M | ||
| Q1 25 | $-6.5M | $-21.5M | ||
| Q4 24 | $-5.8M | $-18.8M | ||
| Q3 24 | $-2.1M | $-25.5M | ||
| Q2 24 | $-5.9M | $-20.9M | ||
| Q1 24 | $-7.0M | $-24.1M |
| Q4 25 | -38.4% | -516.0% | ||
| Q3 25 | -29.3% | — | ||
| Q2 25 | -31.3% | -1347.1% | ||
| Q1 25 | -32.4% | -930.5% | ||
| Q4 24 | -37.1% | -985.8% | ||
| Q3 24 | -29.2% | -1448.4% | ||
| Q2 24 | -55.6% | -1915.4% | ||
| Q1 24 | -103.6% | -713.3% |
| Q4 25 | -54.4% | -507.8% | ||
| Q3 25 | -66.5% | — | ||
| Q2 25 | -60.0% | -1353.6% | ||
| Q1 25 | -68.7% | -935.2% | ||
| Q4 24 | -61.2% | -929.0% | ||
| Q3 24 | -23.6% | -1427.5% | ||
| Q2 24 | -70.1% | -1882.0% | ||
| Q1 24 | -115.9% | -705.4% |
| Q4 25 | $-0.08 | $-0.08 | ||
| Q3 25 | $-0.14 | $-0.09 | ||
| Q2 25 | $-0.13 | $-0.09 | ||
| Q1 25 | $-0.14 | $-0.08 | ||
| Q4 24 | $-0.14 | $-0.07 | ||
| Q3 24 | $-0.05 | $-0.10 | ||
| Q2 24 | $-0.15 | $-0.09 | ||
| Q1 24 | $-0.20 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.2M | $246.9M |
| Total Assets | $70.9M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $319.8M | ||
| Q3 25 | — | $297.3M | ||
| Q2 25 | — | $312.8M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | $100.0K | $139.0M | ||
| Q3 24 | — | $157.7M | ||
| Q2 24 | — | $172.7M | ||
| Q1 24 | — | $124.0M |
| Q4 25 | $26.2M | $246.9M | ||
| Q3 25 | $22.6M | $219.0M | ||
| Q2 25 | $28.4M | $248.7M | ||
| Q1 25 | $28.6M | $55.1M | ||
| Q4 24 | $35.0M | $71.5M | ||
| Q3 24 | $41.2M | $88.8M | ||
| Q2 24 | $42.7M | $108.9M | ||
| Q1 24 | $44.8M | $53.8M |
| Q4 25 | $70.9M | $343.3M | ||
| Q3 25 | $66.7M | $316.6M | ||
| Q2 25 | $70.0M | $333.3M | ||
| Q1 25 | $71.7M | $138.4M | ||
| Q4 24 | $85.5M | $160.4M | ||
| Q3 24 | $87.3M | $180.2M | ||
| Q2 24 | $89.0M | $200.4M | ||
| Q1 24 | $93.3M | $153.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $381.0K | $-26.7M |
| Free Cash FlowOCF − Capex | $346.0K | — |
| FCF MarginFCF / Revenue | 3.6% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $381.0K | $-26.7M | ||
| Q3 25 | $-5.5M | $-24.2M | ||
| Q2 25 | $-4.5M | $-20.2M | ||
| Q1 25 | $-1.8M | $-22.0M | ||
| Q4 24 | $-2.4M | $-18.3M | ||
| Q3 24 | $1.5M | $-21.6M | ||
| Q2 24 | $-6.5M | $-21.5M | ||
| Q1 24 | $3.8M | $-19.8M |
| Q4 25 | $346.0K | — | ||
| Q3 25 | $-5.5M | $-24.3M | ||
| Q2 25 | $-4.5M | — | ||
| Q1 25 | $-1.8M | — | ||
| Q4 24 | $-2.4M | $-18.3M | ||
| Q3 24 | $1.5M | $-21.6M | ||
| Q2 24 | — | $-21.7M | ||
| Q1 24 | $3.8M | $-19.9M |
| Q4 25 | 3.6% | — | ||
| Q3 25 | -56.0% | — | ||
| Q2 25 | -44.1% | — | ||
| Q1 25 | -19.4% | — | ||
| Q4 24 | -25.6% | -905.5% | ||
| Q3 24 | 17.1% | -1210.9% | ||
| Q2 24 | — | -1951.9% | ||
| Q1 24 | 62.7% | -584.5% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.5% | 0.1% | ||
| Q3 24 | 0.4% | 2.0% | ||
| Q2 24 | 0.0% | 18.1% | ||
| Q1 24 | 0.6% | 4.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TOON
| Other | $4.6M | 48% |
| CA | $2.8M | 29% |
| Content Distribution | $2.2M | 23% |
TSHA
Segment breakdown not available.
